Adaptive Biotechnologies (ADPT) Change in Receivables (2018 - 2026)
Adaptive Biotechnologies (ADPT) posted Change in Receivables of -$2.0 million for Q1 2026, down 136.98% sequentially from $5.5 million in Q4 2025, and down 209.98% YoY from $1.9 million in Q1 2025.
Adaptive Biotechnologies (ADPT) Change in Receivables (2018 - 2026) Analysis & Trends
Adaptive Biotechnologies (ADPT) has 9 years of Change in Receivables data on file, last reported at -$2.0 million in Q1 2026.
- Quarterly Change in Receivables fell 209.98% year-over-year to -$2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.7 million (up 204.11% YoY) and the FY2025 annual result came in at $8.6 million, up 130.93% from the prior year.
- Change in Receivables slipped to -$2.0 million in Q1 2026 per ADPT's latest filing, from $5.5 million in the prior quarter.
- The five-year high for Change in Receivables was $13.5 million in Q4 2022, with the low at -$9.1 million in Q1 2023.
- Average Change in Receivables over 5 years is $1.8 million, with a median of $1.2 million recorded in 2022.
- Year-over-year, Change in Receivables surged 4606.97% in 2022 and plunged 1132.37% in 2024.
- Adaptive Biotechnologies' Change in Receivables stood at $13.5 million in 2022, then tumbled by 49.91% to $6.8 million in 2023, then plunged by 86.71% to $899000.0 in 2024, then jumped by 516.69% to $5.5 million in 2025, then tumbled by 136.98% to -$2.0 million in 2026.
- Business Quant data shows ADPT's Change in Receivables at -$2.0 million in Q1 2026, $5.5 million in Q4 2025, and $536000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 533.00 Mn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | - |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -66.00 Mn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 56.81 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 121.07 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | -12.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | - |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -118.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -65.11 Mn |
| 10 | Adaptive Biotechnologies | 3.48 Bn | 3.27 Bn | 52.17 Mn | -2.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.05 Mn |
| Mar 31, 2026 | -2.05 Mn |
| Dec 31, 2025 | 5.54 Mn |
| Dec 31, 2025 | 5.54 Mn |
| Sep 30, 2025 | 536,000.00 |
| Sep 30, 2025 | 536,000.00 |
| Jun 30, 2025 | 702,000.00 |
| Jun 30, 2025 | 702,000.00 |
| Mar 31, 2025 | 1.86 Mn |
| Mar 31, 2025 | 1.86 Mn |
| Dec 31, 2024 | 899,000.00 |
| Dec 31, 2024 | 899,000.00 |
| Sep 30, 2024 | 5.20 Mn |
| Sep 30, 2024 | 5.20 Mn |
| Jun 30, 2024 | -6.41 Mn |
| Jun 30, 2024 | -6.41 Mn |
| Mar 31, 2024 | 4.05 Mn |
| Mar 31, 2024 | 4.05 Mn |
| Dec 31, 2023 | 6.77 Mn |
| Dec 31, 2023 | 6.77 Mn |